HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PR 350

structure given in first source
Also Known As:
PR-350; doranidazole
Networked: 11 relevant articles (3 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nishimura, Yasumasa: 3 articles (06/2008 - 04/2004)
2. Kubota, Nobuo: 2 articles (01/2013 - 09/2005)
3. Sunamura, Makoto: 2 articles (06/2008 - 04/2004)
4. Karasawa, Katsuyuki: 2 articles (06/2008 - 04/2004)
5. Matsuno, Seiki: 2 articles (06/2008 - 04/2004)
6. Nemoto, Kenji: 2 articles (06/2008 - 04/2004)
7. Shibamoto, Yuta: 2 articles (06/2008 - 06/2002)
8. Zhang, Li: 2 articles (01/2007 - 03/2002)
9. Kobayashi, Ataru: 2 articles (09/2005 - 06/2002)
10. Kubota, T: 2 articles (08/2000 - 01/2000)

Related Diseases

1. Pancreatic Neoplasms (Pancreatic Cancer)
2. Neoplasms (Cancer)
3. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
4. Glioblastoma (Glioblastoma Multiforme)
5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. azomycin
2. Hematoxylin (Haematoxylon)
3. Eosine Yellowish-(YS) (Eosin)
4. Propidium (Propidium Iodide)
5. A-factor (Streptomyces)

Related Therapies and Procedures

1. Radiotherapy
2. Drug Therapy (Chemotherapy)
3. Intravenous Injections
4. Anesthesia